skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Cannabidiol (CBD) is being looked at more and more by health, beauty and wellness companies for its use in new OTC drugs, cosmetics and food supplements. It is highly controversial because while CBD has many natural health benefits for treating a variety of conditions and symptoms, it is the active ingredient extracted from cannabis which comes from hemp plants, and therefore has a number of regulatory and legal challenges for its use, but also offers some new market opportunities.

HBW Insight has been closely monitoring and reporting on the developments of CBD across the global consumer healthcare industry, which can be accessed from the timeline of articles below:


Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: